| scholarly article | Q13442814 |
| P2093 | author name string | Amr El-Husseini | |
| Mohamed Sobh | |||
| Alaa Sabry | |||
| Ihab Mahmoud | |||
| Fathy El-Basuony | |||
| Nabil Hassan | |||
| Hussein Sheashaa | |||
| Nagy Sayed-Ahmad | |||
| Nohir Taha | |||
| Rashad Hassan | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | idiopathic nephrotic syndrome | Q55787775 |
| cyclosporine | Q367700 | ||
| nephrotic syndrome | Q504790 | ||
| P304 | page(s) | 2433-2438 | |
| P577 | publication date | 2005-10-04 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience | |
| P478 | volume | 20 |
| Q39712811 | Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome |
| Q87402193 | Chapter 3: Steroid-sensitive nephrotic syndrome in children |
| Q83602331 | Clinical course and outcome of children with steroid-sensitive nephrotic syndrome |
| Q53625850 | Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. |
| Q93044523 | Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome |
| Q37045835 | Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children |
| Q38597096 | Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome |
| Q37315097 | Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie |
| Q35770771 | Cyclosporine A - treated nephrotic children show impaired vasodilatation but no autonomic neuropathy |
| Q88380128 | Cyclosporine A responsive congenital nephrotic syndrome with single heterozygous variants in NPHS1, NPHS2, and PLCE1 |
| Q37553134 | Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial |
| Q37680867 | Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria |
| Q80786696 | Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial |
| Q50202874 | Effectiveness and nephrotoxicity of a 2-year medium dose of cyclosporine in pediatric patients with steroid-dependent nephrotic syndrome: determination of the need for follow-up kidney biopsy |
| Q99616223 | Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial |
| Q60054138 | Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea |
| Q90677029 | Exploring the Clinical and Genetic Spectrum of Steroid Resistant Nephrotic Syndrome: The PodoNet Registry |
| Q92409094 | Hypertension in Childhood Nephrotic Syndrome |
| Q57176874 | Idiopathic nephrotic syndrome in children |
| Q52838570 | Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. |
| Q46091412 | Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study |
| Q41426671 | Long-term prognosis of idiopathic nephrotic syndrome in children |
| Q47270106 | Low birth weight, but not postnatal weight gain, aggravates the course of nephrotic syndrome |
| Q40039238 | Nephrotic syndrome in infants and children: pathophysiology and management |
| Q38854254 | Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment |
| Q37828086 | New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome |
| Q83821639 | Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome |
| Q36284830 | Pharmacokinetics of cyclosporin--a microemulsion in children with idiopathic nephrotic syndrome |
| Q44410073 | Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis |
| Q57945954 | References |
| Q37330330 | Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome |
| Q83327771 | Rituximab for refractory cases of childhood nephrotic syndrome |
| Q42723614 | Second-line options for refractory steroid-sensitive and -resistant nephrotic syndrome |
| Q84951697 | Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome |
| Q81312382 | Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy |
| Q37571486 | The Usefulness of Determining Neutrophil Gelatinase-Associated Lipocalin Concentration Excreted in the Urine in the Evaluation of Cyclosporine A Nephrotoxicity in Children with Nephrotic Syndrome |
| Q35614311 | Therapeutic approach to FSGS in children |
| Q38050961 | Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. |
| Q84415164 | Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome |
| Q36294318 | Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children |
| Q26827717 | Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A Review |
| Q33710267 | Ventricular septal defect in a child with Alport syndrome: a case report |
Search more.